The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
CTX-M: changing the face of ESBLs in Europe
Abstract
Since around 2000 - earlier in Poland and Spain and later in France and the UK - dramatic shifts have occurred in the prevalence and types of extended-spectrum beta-lactamases (ESBLs) in Europe. Before this watershed, most producers were nosocomial isolates, often Klebsiella spp. or Enterobacter spp. from specialist care units, and had mutant TEM or SHV ESBLs. Subsequently, CTX-M ESBLs have become dominant, with much greater penetration into Escherichia coli, and with many infections in 'complicated community' patients, usually with underlying disease, recent antibiotic usage, or healthcare contact. The degree of clonality among producers varies with the country, as does the enzyme type produced, with group 9 (CTX-M-9 and -14) enzymes dominant in Spain and group 1 enzymes (particularly CTX-M-3 and -15) dominant elsewhere. Irrespective of the particular enzyme, most producers are multiresistant. These changing patterns present major therapeutic and infection control challenges, with the public health intervention points unclear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M., Cheasty, T., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh424 · Cited by 472
Self-citationRodríguez-Baño, J., Navarro, M. D., Romero, L., Martínez-Martínez, L., Muniain, M. A., Perea, E. J., Pérez-Cano, R., & Pascual, A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1089-1094.2004 · Cited by 456
Boyd, D. A., Tyler, S., Christianson, S., McGeer, A., Muller, M. P., Willey, B. M., Bryce, E., Gardam, M., Nordmann, P., & Mulvey, M. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3758-3764.2004 · Cited by 389
Self-citationColodner, R., Rock, W., Chazan, B., Keller, N., Guy, N., Sakran, W., & Raz, R. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1084-2 · Cited by 364
A new plasmidic cefotaximase in a clinical isolate of Escherichia coli
Bauernfeind, A., Schweighart, S., & Grimm, H. (1990) · Infection · doi:10.1007/bf01647010 · Cited by 363
Karim, A., Poirel, L., Nagarajan, S., & Nordmann, P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10762.x · Cited by 359
Self-citationPoirel, L., Decousser, J.-W., & Nordmann, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2938-2945.2003 · Cited by 357
Self-citationSaladin, M., Cao, V. T. B., Lambert, T., Donay, J.-L., Herrmann, J.-L., Ould-Hocine, Z., Verdet, C., Delisle, F., Philippon, A., & Arlet, G. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11126.x · Cited by 348
Self-citationValverde, A., Coque, T. M., Sánchez-Moreno, M. P., Rollán, A., Baquero, F., & Cantón, R. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4769-4775.2004 · Cited by 333
Self-citation
Cited by
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Self-citationExtended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Resistance Plasmid Families in Enterobacteriaceae
Carattoli, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01707-08 · Cited by 1,229
CTX-M Enzymes: Origin and Diffusion
Cantón, R., González-Alba, J. M., & Galán, J. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00110 · Cited by 974
Epidemiology of β-Lactamase-Producing Pathogens
Bush, K., & Bradford, P. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-19 · Cited by 938
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Self-citationIntercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Nicolas-Chanoine, M.-H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Canica, M. M., Park, Y.-J., Lavigne, J.-P., Pitout, J., & Johnson, J. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm464 · Cited by 821
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe
Coque, T. M., Baquero, F., & Cantón, R. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19044-en · Cited by 799
Self-citationExtended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
Castanheira, M., Simner, P. J., & Bradford, P. A. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab092 · Cited by 796
Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype
Bevan, E. R., Jones, A. M., & Hawkey, P. M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx146 · Cited by 791
Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence
Christaki, E., Marcou, M., & Tofarides, A. (2020) · Journal of Molecular Evolution · doi:10.1007/s00239-019-09914-3 · Cited by 780
Bacterial septic arthritis in adults
Mathews, C. J., Weston, V. C., Jones, A., Field, M., & Coakley, G. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61595-6 · Cited by 774
The changing epidemiology of resistance
Hawkey, P. M., & Jones, A. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp256 · Cited by 773
Coque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070350 · Cited by 702
Self-citationHas the era of untreatable infections arrived?
Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp255 · Cited by 620
Self-citationPrevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe
Cantón, R., Novais, A., Valverde, A., Machado, E., Peixe, L., Baquero, F., & Coque, T. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01850.x · Cited by 599
Self-citationInterplay between β-lactamases and new β-lactamase inhibitors
Bush, K., & Bradford, P. A. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0159-8 · Cited by 531
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
Pfeifer, Y., Cullik, A., & Witte, W. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.005 · Cited by 494
Escherichia coli in Europe: An Overview
Allocati, N., Masulli, M., Alexeyev, M., & Di Ilio, C. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10126235 · Cited by 471
Peirano, G., & Pitout, J. D. D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.003 · Cited by 443
Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
Livermore, D. M. (2012) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2012.27.2.128 · Cited by 417
Self-citationGuenther, S., Ewers, C., & Wieler, L. H. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00246 · Cited by 388
Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
Rodríguez-Baño, J., Alcalá, J. C., Cisneros, J. M., Grill, F., Oliver, A., Horcajada, J. P., Tórtola, T., Mirelis, B., Navarro, G., Cuenca, M., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.17.1897 · Cited by 379
Pitout, J. D. D. (2010) · Drugs · doi:10.2165/11533040-000000000-00000 · Cited by 376
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
Dalhoff, A. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/976273 · Cited by 354
Extended-spectrum β-lactamase-producing organisms
Falagas, M. E., & Karageorgopoulos, D. E. (2009) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.02.021 · Cited by 346
Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria
Zhao, W.-H., & Hu, Z.-Q. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.691460 · Cited by 302
The continuing challenge of ESBLs
PEREZ, F., ENDIMIANI, A., HUJER, K., & BONOMO, R. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.08.003 · Cited by 298
Seiffert, S. N., Hilty, M., Perreten, V., & Endimiani, A. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2012.12.001 · Cited by 296
Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance
Salverda, M. L. M., De Visser, J. A. G. M., & Barlow, M. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00222.x · Cited by 289
Woodford, N., Carattoli, A., Karisik, E., Underwood, A., Ellington, M. J., & Livermore, D. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00688-09 · Cited by 283
Self-citationEwers, C., Grobbel, M., Stamm, I., Kopp, P. A., Diehl, I., Semmler, T., Fruth, A., Beutlich, J., Guerra, B., Wieler, L. H., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq004 · Cited by 279
Clermont, O., Lavollay, M., Vimont, S., Deschamps, C., Forestier, C., Branger, C., Denamur, E., & Arlet, G. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn084 · Cited by 274
Self-citationMurphy, C. N., Fowler, R., Balada-Llasat, J. M., Carroll, A., Stone, H., Akerele, O., Buchan, B., Windham, S., Hopp, A., Ronen, S., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00128-20 · Cited by 269
Kanj, S. S., & Kanafani, Z. A. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0674 · Cited by 269
β-Lactam resistance and β-lactamases in bacteria of animal origin
Li, X.-Z., Mehrotra, M., Ghimire, S., & Adewoye, L. (2007) · Veterinary Microbiology · doi:10.1016/j.vetmic.2007.01.015 · Cited by 266
Kiratisin, P., Apisarnthanarak, A., Laesripa, C., & Saifon, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00171-08 · Cited by 261
(BIOHAZ), E. P. O. B. H. (2011) · EFSA Journal · doi:10.2903/j.efsa.2011.2322 · Cited by 258
Kahlmeter, G., & Poulsen, H. O. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.013 · Cited by 256
Bonnedahl, J., Drobni, M., Gauthier-Clerc, M., Hernandez, J., Granholm, S., Kayser, Y., Melhus, Å., Kahlmeter, G., Waldenström, J., Johansson, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005958 · Cited by 252
Meyer, E., Gastmeier, P., Kola, A., & Schwab, F. (2012) · Infection · doi:10.1007/s15010-012-0324-8 · Cited by 112
Escalating antimicrobial resistance among Enterobacteriaceae: Focus on carbapenemases
Lynch, J. P., Clark, N. M., & Zhanel, G. G. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1904891 · Cited by 58
Bulabula, A. N. H., Dramowski, A., & Mehtar, S. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.08.015 · Cited by 64
Filho, J. R. D. C., Silva, R. M., Castanheira, M., Tognim, M. C. B., Gales, A. C., & Sader, H. S. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.5.600 · Cited by 12
Mahmud, Z., Shabnam, S. A., Mishu, I. D., Johura, F.-T., Mannan, S. B., Sadique, A., Islam, L. N., & Alam, M. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101182 · Cited by 9
Influence of zinc on CTX-M-1 β-lactamase expression in escherichia coli
Peng, S., Herrero-Fresno, A., Olsen, J. E., & Dalsgaard, A. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.06.004 · Cited by 7
de Jong, A., Temmerman, R., Sweeney, M. T., & El Garch, F. (2025) · Antimicrobial Food Packaging · doi:10.1016/b978-0-323-90747-7.00010-7 · Cited by 1
Metadata
- Authors
- Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., Poirel, L., & Woodford, N.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-11-13
- Volume
- 59
- Issue
- 2
- Pages
- 165-174
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2108864681
- Cited by
- 927
- References
- 80
- FWCI
- 24.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.